These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35154110)

  • 21. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
    Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK
    Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
    Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
    Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS; Wulff CR; Garvy BA; Straley SC
    Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
    Lin JS; Park S; Adamovicz JJ; Hill J; Bliska JB; Cote CK; Perlin DS; Amemiya K; Smiley ST
    Vaccine; 2010 Dec; 29(2):357-62. PubMed ID: 20840834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.
    Williamson ED; Packer PJ; Waters EL; Simpson AJ; Dyer D; Hartings J; Twenhafel N; Pitt ML
    Vaccine; 2011 Jun; 29(29-30):4771-7. PubMed ID: 21570437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.
    D'Arco C; McCormick AA; Arnaboldi PM
    Vaccine; 2021 Mar; 39(9):1435-1444. PubMed ID: 33531196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a Live-Attenuated Vaccine Strain of
    Feng J; Deng Y; Fu M; Hu X; Luo W; Lu Z; Dai L; Yang H; Zhao X; Du Z; Wen B; Jiang L; Zhou D; Jiao J; Xiong X
    Front Cell Infect Microbiol; 2020; 10():473. PubMed ID: 33014895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines.
    Tao P; Mahalingam M; Kirtley ML; van Lier CJ; Sha J; Yeager LA; Chopra AK; Rao VB
    PLoS Pathog; 2013; 9(7):e1003495. PubMed ID: 23853602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against pneumonic plague following oral immunization with a non-replicating vaccine.
    Jones A; Bosio C; Duffy A; Goodyear A; Schriefer M; Dow S
    Vaccine; 2010 Aug; 28(36):5924-9. PubMed ID: 20600517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of Protective Antiplague Immune Responses by Self-Adjuvanting Bionanoparticles Derived from Engineered Yersinia pestis.
    Wang X; Singh AK; Zhang X; Sun W
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32152195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manganese-Based Nanoparticle Vaccine for Combating Fatal Bacterial Pneumonia.
    OuYang X; Xu X; Qin Q; Dai C; Wang H; Liu S; Hu L; Xiong X; Liu H; Zhou D
    Adv Mater; 2023 Dec; 35(51):e2304514. PubMed ID: 37784226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
    Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague.
    Wagner DA; Kelly SM; Petersen AC; Peroutka-Bigus N; Darling RJ; Bellaire BH; Wannemuehler MJ; Narasimhan B
    Acta Biomater; 2019 Dec; 100():326-337. PubMed ID: 31610342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
    Branger CG; Fetherston JD; Perry RD; Curtiss R
    Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection.
    Verma SK; Gupta A; Batra L; Tuteja U
    Vaccine; 2019 Jan; 37(1):19-24. PubMed ID: 30497835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine.
    Airhart CL; Rohde HN; Hovde CJ; Bohach GA; Deobald CF; Lee SS; Minnich SA
    Vaccine; 2008 Oct; 26(44):5554-61. PubMed ID: 18722493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague.
    Kumar D; Kirimanjeswara G; Metzger DW
    Clin Vaccine Immunol; 2011 Nov; 18(11):1925-35. PubMed ID: 21880856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational considerations about development of live attenuated Yersinia pestis vaccines.
    Sun W; Curtiss R
    Curr Pharm Biotechnol; 2013; 14(10):878-86. PubMed ID: 24372254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.
    Tao P; Mahalingam M; Zhu J; Moayeri M; Sha J; Lawrence WS; Leppla SH; Chopra AK; Rao VB
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.